ArticleFrontiers in cellular and infection microbiology2026
Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Globally, Osteoarthritis (OA) represents a primary chronic joint condition, rooted in complex mechanisms such as metabolic irregularities, synovitis, immune system responses, and body-wide inflammation. Emerging evidence highlights gut microbiota as a critical mediator of joint inflammation. Methods: In this study, 55 OA patients from the affiliated hospital of Anhui Medical University were compared with 55 healthy controls. Using 16S rRNA (V4-V5) sequencing and POS/NEG dualionmode untargeted fecal metabolomics, we investigated the "gutmetabolismimmunityjoint" axis in OA. Results: The results indicate that patients with OA exhibit significant gut microbiota dysbiosis, characterised in particular by a reduction in beneficial bacterial groups such as Discussion: This study revealed significant alterations in gut microbiota and fecal metabolites in OA patients compared to healthy individuals. The identified differential metabolites hold promise as potential biomarkers for early diagnosis or therapeutic targets, offering new insights for future personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.